
Sana Biotechnology, Inc. Common Stock
SANA
SANA: Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. Its operations include identifying and developing potential product candidates, executing preclinical studies, establishing manufacturing capabilities, acquiring technology, organizing and staffing the Company, business planning, establishing the company's intellectual property portfolio, raising capital, and providing general and administrative support for these operations.
moreShow SANA Financials
Recent trades of SANA by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by SANA's directors and management
Government lobbying spending instances
New patents grants
-
Patent Title: Cryogenic cassette Jul. 04, 2023
-
Patent Title: Cd8-specific antibody constructs and compositions thereof Dec. 27, 2022
Federal grants, loans, and purchases
Followers on SANA's company Twitter account
Number of mentions of SANA in WallStreetBets Daily Discussion
Recent insights relating to SANA
Recent picks made for SANA stock on CNBC
ETFs with the largest estimated holdings in SANA
Flights by private jets registered to SANA